ArticleCureus2024

The Prevalence of Programmed Death Ligand-1 (PD-L1) Expression in Non-Small Cell Lung Cancer: An Experience From Tertiary Care Hospital.

Asmita Mehta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.